Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | MSLE Satellos Bioscience Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $8.70 -0.1% | $14.86 -2.5% |
| StockIQ Score | 48D+ Moderate Risk: Medium | 36F Weak Risk: Medium |
| Technical | 41D | 13F |
| Fundamental | 50C- | 35F |
| Growth | 46D+ | 50C- |
| Fair Value | 38F | 38F |
| News | 74B | 50C- |
| Quality | 55C | 50C- |
| Risk | 46D+ | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
MSLE has a higher investorScore (48 vs 36) and a better rating (MODERATE vs WEAK). Its technicalScore (41) and fundamentalScore (50) also exceed AAPG’s (13 and 35). AAPG leads only in growthScore (50 vs 46), while both share the same valuationScore of 38.
